Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
The sleep–circadian interface: A window into mental disorders
2024 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Works of Corinne Staner being referenced
Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms
2018
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Corinne Staner | 293 | 295 | 186 | 12 | 490 | |
| Sylvie Chouinard | 250 | 187 | 46 | 14 | 420 | |
| Stephan Krieger | 203 | 136 | 82 | 11 | 570 | |
| Christine M. Walsh | 273 | 141 | 110 | 19 | 506 | |
| David J. Kupfer | 287 | 290 | 143 | 11 | 517 | |
| Nadine Petrovsky | 213 | 119 | 45 | 19 | 521 | |
| H.A. Droogleever Fortuyn | 296 | 266 | 136 | 9 | 511 | |
| Catherine Hatfield | 149 | 138 | 158 | 9 | 435 | |
| E. DuBoff | 168 | 354 | 53 | 12 | 554 | |
| Gabriel Esquivel | 72 | 196 | 43 | 18 | 491 | |
| Bernd Strebel | 87 | 79 | 123 | 11 | 441 |
All Works
Loading papers...